EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES

EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES

Show other versions (1)

Aim. To compare the dynamics of intrarenal vascular resistance (IRVR), circadian blood pressure (BP) profile and glomerular filtration rate (GFR) in patients with arterial hypertension (HT) and type 2 diabetes mellitus (DM) who achieved the target BP levels (<130/80 mmHg) due to long-term com...

Full description

Bibliographic Details
Main Authors:	O. A. Koshel'skaya, O. A. Zhuravleva
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-12-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	intrarenal vascular resistance diabetes mellitus arterial hypertension target blood pressure combined antihypertensive treatment renin-angiotensin-aldosterone system inhibitors glomerular filtration rate
Online Access:	https://www.rpcardio.online/jour/article/view/464

Similar Items

Algorithm for differential administration of combination antihypertensive therapy in patients with Type 2 diabetes mellitus
by: O. A. Koshelskaya, et al.
Published: (2013-08-01)

The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism
by: Piotr Jędrusik, et al.
Published: (2021-05-01)

EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN ACHIEVEMENT OF TARGET BLOOD PRESSURE IN DIABETIC PATIENTS
by: O. A. Koshel'skaya, et al.
Published: (2015-12-01)

Research Progress on Antihypertensive Effect of Polysaccharide and Its Mechanism
by: Jilong XU, et al.
Published: (2023-02-01)

Markers of chronic kidney disease and disorders of renal hemodynamics in patients with medically-controlled arterial hypertension and high and very high cardiovascular risk
by: O. A. Koshel'skaya, et al.
Published: (2018-11-01)

CHRONIC RENAL DISEASE: RISK FACTORS, EARLY DETECTION, PRINCIPLES OF ANTIHYPERTENSIVE THERAPY
by: A. M. Easyan
Published: (2017-11-01)

The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer
by: José A. Carlos-Escalante, et al.
Published: (2021-05-01)

EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES
by: O. A. Koshel'skaya, et al.
Published: (2015-12-01)

Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive Patients
by: Annina S. Vischer, et al.
Published: (2021-03-01)

Overexpression of Intrarenal Renin-Angiotensin System in Human Acute Tubular Necrosis
by: Wei Cao, et al.
Published: (2016-10-01)

Blood Pressure Control and Antihypertensive Treatment among Hemodialysis Patients—Retrospective Single Center Experience
by: Piotr Skonieczny, et al.
Published: (2021-06-01)

Prospects of using genetic testing to increase the effectiveness of antihypertensive therapy
by: N. V. Drobotya, et al.
Published: (2020-06-01)

PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL
by: N. A. Morina, et al.
Published: (2017-11-01)

Efficacy of valsartan in the therapy of persistent microalbuminuria in normotensive patients with type 1 diabetes mellitus
by: Dragović Tamara, et al.
Published: (2003-01-01)

Polymorphism of genes-candidates of renin-angiotensin-aldosteronovy system (ACE, AGT, AGTR1) and effectiveness of treatment of arterial hypertension. Results of research in Mountain Shoria
by: Tatyana A. Mulerova, et al.
Published: (2021-02-01)

Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy
by: Kalathil K Sureshkumar
Published: (2008-12-01)

Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
by: M L Maksimov
Published: (2010-06-01)

THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: V. I. Podzolkov, et al.
Published: (2016-01-01)

Foe and friend in the COVID-19-associated acute kidney injury: an insight on intrarenal renin-angiotensin system
by: Xu Chuanming, et al.
Published: (2021-12-01)

Genetic pathogenesis of essential arterial hypertension (the review)
by: Ruta A.V., et al.
Published: (2011-03-01)

Renin-Angiotensin-Aldosterone System Modulates Blood Pressure Response During Vascular Endothelial Growth Factor Receptor Inhibition
by: Wendy J. Bottinor, MD, MSCI, et al.
Published: (2019-09-01)

Neurohumoral regulation of blood pressure in rheumatic patients
by: N P Shilkina, et al.
Published: (2009-06-01)

Urinary angiotensinogen level is correlated with blood pressure level and proteinuria in patients with masked hypertension
by: Ozlem Tiryaki, et al.
Published: (2018-10-01)

The relationship of plasma renin, angiotensin, and aldosterone levels to blood pressure variability and target organ damage in children with essential hypertension
by: Yang Liu, et al.
Published: (2020-06-01)

Effect of sodium–glucose cotransporter-2 inhibitors on aldosterone-to-renin ratio in diabetic patients with hypertension: a retrospective observational study
by: Toshitaka Sawamura, et al.
Published: (2020-11-01)

RAA System and Exercise Relationship
by: Sadettin Ünsal, et al.
Published: (2019-09-01)

Antihypertensive effects of pentacyclic triterpenoid from Convolvulus pluricaulis and its plausible mechanism of action hypothesizing its selectivity targeting Mineralocorticoid receptor of RAAS.
by: Kanagasabai Somarathinam, et al.
Published: (2023-02-01)

Dynamic changes of renin-angiotensin-aldosterone system parameters after surgery of primary hyperparathyroidism
by: E. A. Dobreva, et al.
Published: (2020-11-01)

Nocturnal diastolic blood pressure decline is associated with higher 25-hydroxyvitamin D level and standing plasma renin activity in a hypertensive population
by: Mingchen Zhang, et al.
Published: (2017-11-01)

Renin-angiotensin system antagonists, glomerular filtration rate and blood pressure
by: D.D. Ivanov
Published: (2018-02-01)

Hypertension in COVID-19, A Risk Factor for Infection or A Late Consequence?
by: Maryam Barekat, et al.
Published: (2022-07-01)

Primary aldosteronism and obstructive sleep apnea: What do we know thus far?
by: Huai Heng Loh, et al.
Published: (2022-09-01)

Role of renin–angiotensin aldosterone system on short-term blood pressure variability in hypertensive patients
by: Minako Inoue, et al.
Published: (2018-10-01)

Neuro-endocrine regulation of blood pressure
by: Sandeep Chopra, et al.
Published: (2011-01-01)

Effect of a fixed-dose perindopril and amlodipine combination on intrarenal hemodynamic and kidney functional parameters in patients with essential hypertension
by: B G Iskenderov, et al.
Published: (2013-05-01)

Aliskiren: An orally active renin inhibitor
by: Pranay Wal, et al.
Published: (2011-01-01)

LONG-TERM EFFECTS OF OLMESARTAN, AN ANG II RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: Shuichi Ichikawa, et al.
Published: (2011-06-01)

EFFECTIVENESS OF FIXED COMBINATION OF RAMIPIL/AMLODIPINE IN THERAPY OF ARTERIAL HYPERTENSION, CHRONIC KIDNEY DISEASE AND DIABETES MELLITUS
by: O. D. OSTROUMOVA, et al.
Published: (2016-12-01)

Sartans in the treatment of high-risk hypertension: the abilities of candesartan
by: T E Morozova
Published: (2013-06-01)

CLINICAL ASSOCIATIONS BETWEEN CORONAVIRUS INFECTION (COVID-19) AND ARTERIAL HYPERTENSION: PATHOGENETIC MECHANISMS AND DISCUSSION ON THE USE OF INHIBITORS OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
by: Yakubava L. V., et al.
Published: (2020-11-01)